Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901

Clinical trial NCT04396457 · UNKNOWN

Trial details

NCT number: NCT04396457
Sponsor: National Hospital Organization Nagoya Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-squamous Non-small-cell Lung Cancer Cancer, Lung

Start date: 2020-05-25
Primary completion: 2023-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.